Author

A. Krzywon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. J. Cortez· 1 shared A. K. Kheirallah· 1 shared A. Roggy· 1 shared A. Toma-Jonik· 1 shared B. Gielniewski· 1 shared B. Wojtas· 1 shared C. Preudhomme· 1 shared C. Roumier· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Cortez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Heat Shock Factor 1 (HSF1) as a new tethering factor for ESR1 supporting its action in breast cancer.

N. Vydra, P. Janus, P. Kus, T. Stokowy, K. Mrowiec, A. Toma-Jonik, A. Krzywon, A. J. Cortez, B. Wojtas, B. Gielniewski, R. Jaksik, M. Kimmel, W. Widlak

This study shows HSF1 enhances ESR1's genomic action in breast cancer, increases transcriptome diversity, and together they predict poor prognosis in ER-negative cancers.

bioRxiv · May 6, 2021Cancer Biology

A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis

J. Bond, A. Krzywon, L. Lhermitte, C. Roumier, A. Roggy, M. Belhocine, A. K. Kheirallah, P. Villarese, G. Hypolite, F. Garnache-Ottou, S. Castaigne, N. Boissel, V. Asnafi, C. Preudhomme, H. Dombret, , E. Macintyre

The paper identifies a transcriptomic continuum of differentiation arrest in acute leukemias, finding that myeloid/T-lymphoid interface leukemias (IALs) correlate with poor prognosis in AML.

bioRxiv · Dec 10, 2019Cancer Biology